Stockscreener 앱 받기
136.71
3.72%
4.91
전일 마감가:
$131.80
열려 있는:
$131.78
하루 거래량:
453.78K
Relative Volume:
0.62
시가총액:
$8.30B
수익:
$3.99B
순이익/손실:
$463.16M
주가수익비율:
19.25
EPS:
7.1
순현금흐름:
$1.10B
1주 성능:
+5.49%
1개월 성능:
+7.01%
6개월 성능:
+9.37%
1년 성능:
+25.37%
1일 변동 폭
$131.76
$137.50
1주일 범위
$125.78
$137.50
52주 변동 폭
$95.49
$148.06
Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile
명칭
Jazz Pharmaceuticals Plc
전화
353-1-634-7800
주소
FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN
JAZZ을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
JAZZ
Jazz Pharmaceuticals Plc
|
136.82 | 7.99B | 3.99B | 463.16M | 1.10B | 7.10 |
|
VRTX
Vertex Pharmaceuticals Inc
|
403.64 | 100.41B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
605.96 | 59.59B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.86 | 59.77B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
773.12 | 45.14B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
343.13 | 37.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-15 | 개시 | Deutsche Bank | Buy |
| 2025-03-07 | 업그레이드 | UBS | Neutral → Buy |
| 2025-02-26 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2025-02-13 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-12-12 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-06-05 | 개시 | Goldman | Buy |
| 2024-01-03 | 개시 | Robert W. Baird | Outperform |
| 2023-11-27 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-09-29 | 개시 | Raymond James | Mkt Perform |
| 2023-06-12 | 재개 | Wells Fargo | Equal Weight |
| 2022-12-09 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-06-14 | 개시 | UBS | Buy |
| 2022-04-06 | 다운그레이드 | Goldman | Buy → Neutral |
| 2021-11-19 | 재개 | Goldman | Buy |
| 2021-10-07 | 재개 | Jefferies | Buy |
| 2021-10-05 | 개시 | Citigroup | Buy |
| 2021-09-23 | 개시 | Needham | Buy |
| 2021-05-19 | 재개 | JP Morgan | Overweight |
| 2021-04-07 | 재개 | RBC Capital Mkts | Outperform |
| 2021-02-05 | 재확인 | H.C. Wainwright | Buy |
| 2021-02-03 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-01-29 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-16 | 개시 | UBS | Buy |
| 2020-11-03 | 재확인 | H.C. Wainwright | Buy |
| 2020-10-09 | 재확인 | H.C. Wainwright | Buy |
| 2020-09-14 | 다운그레이드 | Goldman | Neutral → Sell |
| 2020-09-14 | 재개 | JP Morgan | Overweight |
| 2020-08-06 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-07-28 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-07-23 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-04-06 | 개시 | Jefferies | Buy |
| 2020-03-12 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2020-01-08 | 개시 | Goldman | Neutral |
| 2019-08-21 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2019-06-11 | 개시 | Barclays | Overweight |
| 2019-03-20 | 개시 | SunTrust | Buy |
| 2018-12-14 | 개시 | Wolfe Research | Peer Perform |
| 2018-11-08 | 재확인 | B. Riley FBR | Buy |
| 2018-08-08 | 재확인 | Stifel | Buy |
| 2018-07-11 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2018-03-23 | 재확인 | H.C. Wainwright | Neutral |
| 2018-03-19 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
모두보기
Jazz Pharmaceuticals Plc 주식(JAZZ)의 최신 뉴스
Is Jazz Pharmaceuticals plc a candidate for recovery play2025 Performance Recap & Real-Time Buy Signal Alerts - newser.com
Will Jazz Pharmaceuticals plc stock rally after Fed decisionsJuly 2025 EndofMonth & Fast Exit and Entry Strategy Plans - newser.com
What MACD and RSI say about Jazz Pharmaceuticals plcShare Buyback & Consistent Growth Equity Picks - newser.com
Park Avenue Securities LLC Takes Position in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Will Jazz Pharmaceuticals plc (J7Z) stock remain on Wall Street radarMarket Growth Summary & Free Expert Approved Momentum Trade Ideas - newser.com
Will Jazz Pharmaceuticals plc stock keep outperforming rivals2025 Key Highlights & Reliable Price Breakout Signals - newser.com
Will Jazz Pharmaceuticals plc (J7Z) stock announce special dividendOptions Play & Real-Time Volume Trigger Notifications - newser.com
Why Jazz Pharmaceuticals plc (J7Z) stock could be top winnerJuly 2025 Weekly Recap & Community Consensus Stock Picks - newser.com
Jazz Pharmaceuticals (JAZZ) Stock Analysis: 47% Potential Upside Catches Investor Attention - DirectorsTalk Interviews
Jazz Pharmaceuticals (JAZZ) Stock Analysis: A 47% Upside Potential Beckons Investors - DirectorsTalk Interviews
State of Alaska Department of Revenue Boosts Stake in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
What analysts say about Jazz Pharmaceuticals plc stockFederal Reserve Announcements & Small Investment Trading Tips - earlytimes.in
Jazz Pharmaceuticals plc J7Z Stock Analysis and ForecastTechnical Resistance Breaks & Low Cost Wealth Plans - earlytimes.in
What analysts say about Jazz Pharmaceuticals plc J7Z stockRSI Overbought/Oversold & Free Daily Stock Hotspot Analysis - earlytimes.in
Are Jazz Pharmaceuticals Shares Set for a Rebound After Recent Drug Approval in 2025? - simplywall.st
Piper Sandler Reaffirms Jazz Pharmaceuticals (JAZZ) Price Target Ahead of Trial Data - MSN
What drives Jazz Pharmaceuticals plc stock priceDividend Stock Watch & Exceptional Capital Investment - Early Times
Pharma 50: The top pharma companies in the world for 2025 - drugdiscoverytrends.com
EClinical Solutions Explores Data Intelligence in Modern Clinical Trials at ENGAGE 2025 - MarketScreener
JAZZ: Morgan Stanley Raises Price Target to $167, Maintains Over - GuruFocus
Affinity Wealth Management LLC Purchases New Position in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
United States Myelodysplastic Syndrome Treatment Market - openPR.com
Amneal wins FDA nod for generic targeting Jazz Pharma’s Xyrem - MSN
Jazz Pharmaceuticals Secures Dismissal of Patent Fraud Lawsuit - Bloomberg Law News
Jazz Pharmaceuticals Announces Promising Xywav Data: Why I Assign A BUY Rating - Seeking Alpha
Here's Why JAZZ Stock Is an Unconventional Cannabis Investment - The Globe and Mail
Morgan Stanley Issues Positive Forecast for Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock Price - MarketBeat
Jazz Pharmaceuticals PLC $JAZZ Shares Sold by Perpetual Ltd - MarketBeat
Jazz Pharmaceuticals PLC $JAZZ Shares Bought by CX Institutional - MarketBeat
Jazz Pharmaceuticals plc (JAZZ) Advances Rare Cancer Portfolio with First CNS Glioma Therapy Approval - Yahoo Finance
Jazz Pharmaceuticals stock price target raised to $167 from $163 at Morgan Stanley - Investing.com UK
Jazz Pharmaceuticals (JAZZ): Assessing Valuation Following Fresh Xywav Clinical Data at Leading Medical Conferences - simplywall.st
Wedmont Private Capital Decreases Stake in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Jazz Pharmaceuticals stock hits 52-week high of $134.24 - MSN
Swedbank AB Lowers Stock Holdings in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Jazz pharma presents new data on narcolepsy and hypersomnia treatment - Investing.com
Jazz Pharmaceuticals presents Xywav data at medical conferences - StreetInsider
Jazz Pharmaceuticals Showcases Phase 4 Data Demonstrating Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Effects and Real-World Evidence at World Sleep and Psych Congresses - PR Newswire
United States Narcolepsy Therapeutics Market Trends & Growth - openPR.com
Voya Investment Management LLC Acquires 22,628 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
How NCCN Endorsement of Modeyso May Shape Jazz Pharmaceuticals' (JAZZ) Rare Oncology Expansion - simplywall.st
Jazz Pharmaceuticals PLC $JAZZ Shares Sold by MassMutual Private Wealth & Trust FSB - MarketBeat
Jazz Pharmaceuticals Plc (JAZZ) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.76%
자본화:
|
볼륨(24시간):